University of Chicago NF Clinic Update

Dr. James Tonsgard, longtime neurologist and Director of the Neurofibromatosis (NF) Clinic at the University of Chicago, has announced that he will retire from seeing patients at the end of 2026. Dr. Tonsgard has served as a clinician at the University of Chicago for 49 years and has led a dedicated NF clinic for more…

Read More

Meet the Faces of NF Care

Have you seen our new video series called Meet the Faces of NF Care? This series is designed to give you, the NF community, a chance to learn more about NF care and the dedicated providers in your area (Illinois, Indiana, Iowa, Kentucky, Wisconsin, and Missouri). Through these informative recordings, you’ll gain valuable insights, including:…

Read More

NF Midwest Provides Funds to Help NF Patients

NF Midwest recently provided funds to three NF providers through our Care Impact Grant Program. The NF Care Impact Grant program is an application-based program that  provides funds to selected applicants who have an idea, program, or need that will directly help to improve care, or access to care, to patients with neurofibromatosis. Several months…

Read More

NF Midwest Supports Area Clinical Trials

If you’ve been paying any attention to NF research in the last several years you’ll have noticed that in clinical trials some drugs are showing a lot of promise in the treatment of NF1 plexiform tumors and NF2 tumors. For over 36 years NF Midwest has been funding research for the many complications of neurofibromatosis type 1,…

Read More

New Guidelines for the Care of Adults with NF1

Great news! A new, detailed clinical practice guideline has been made available on the care of adults with neurofibromatosis type 1. This was written to help physicians treat their patients with NF1 and is a great resource to share with your doctor. It’s a wonderful piece published by the The American College of Medical Genetics and Genomics (ACMG)…

Read More